Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer

This study has been completed.
CTI BioPharma
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: December 28, 2005
Last updated: February 11, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)